These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
622 related articles for article (PubMed ID: 16316823)
1. Proteasome inhibition: a new approach for the treatment of malignancies. Spano JP; Bay JO; Blay JY; Rixe O Bull Cancer; 2005 Nov; 92(11):E61-6, 945-52. PubMed ID: 16316823 [TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. Ludwig H; Khayat D; Giaccone G; Facon T Cancer; 2005 Nov; 104(9):1794-807. PubMed ID: 16178003 [TBL] [Abstract][Full Text] [Related]
3. [Proteasome inhibitor bortezomib as an anticancer drug]. Yasui H; Hideshima T Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1251-6. PubMed ID: 16922383 [No Abstract] [Full Text] [Related]
4. Proteasome inhibition as a novel therapeutic target in human cancer. Rajkumar SV; Richardson PG; Hideshima T; Anderson KC J Clin Oncol; 2005 Jan; 23(3):630-9. PubMed ID: 15659509 [TBL] [Abstract][Full Text] [Related]
5. Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies. Caravita T; de Fabritiis P; Palumbo A; Amadori S; Boccadoro M Nat Clin Pract Oncol; 2006 Jul; 3(7):374-87. PubMed ID: 16826218 [TBL] [Abstract][Full Text] [Related]
6. Bortezomib: a novel therapy approved for multiple myeloma. Richardson PG; Anderson KC Clin Adv Hematol Oncol; 2003 Oct; 1(10):596-600. PubMed ID: 16258456 [TBL] [Abstract][Full Text] [Related]
7. The role of proteasome in malignant diseases. Moran E; Nencioni A J BUON; 2007 Sep; 12 Suppl 1():S95-9. PubMed ID: 17935285 [TBL] [Abstract][Full Text] [Related]
8. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer]. Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229 [TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition for treatment of multiple myeloma: clinical update. Stadtmauer EA J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S10-5. PubMed ID: 19795531 [TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition as a therapeutic strategy for hematologic malignancies. Mitsiades CS; Mitsiades N; Hideshima T; Richardson PG; Anderson KC Expert Rev Anticancer Ther; 2005 Jun; 5(3):465-76. PubMed ID: 16001954 [TBL] [Abstract][Full Text] [Related]
11. Cancer research. Taking garbage in, tossing cancer out? Garber K Science; 2002 Jan; 295(5555):612-3. PubMed ID: 11809952 [No Abstract] [Full Text] [Related]
12. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma. Bladé J; Cibeira MT; Rosiñol L Acta Oncol; 2005; 44(5):440-8. PubMed ID: 16118077 [TBL] [Abstract][Full Text] [Related]
13. Effect of noncompetitive proteasome inhibition on bortezomib resistance. Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154 [TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors in cancer therapy. Orlowski RZ Methods Mol Biol; 2005; 301():339-50. PubMed ID: 15917644 [TBL] [Abstract][Full Text] [Related]
17. The proteasome: a novel target for anticancer therapy. Montagut C; Rovira A; Albanell J Clin Transl Oncol; 2006 May; 8(5):313-7. PubMed ID: 16760005 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib and its role in the management of patients with multiple myeloma. Orlowski RZ Expert Rev Anticancer Ther; 2004 Apr; 4(2):171-9. PubMed ID: 15056047 [TBL] [Abstract][Full Text] [Related]
19. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121 [TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors in pediatric cancer treatment. Bachmann AS Hawaii Med J; 2008 Sep; 67(9):247-9. PubMed ID: 18853901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]